網膜静脈閉塞(Retinal Vein Occlusion)：世界の治験レビュー（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Retinal Vein Occlusion 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Retinal Vein Occlusion to Ophthalmology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Retinal Vein Occlusion to Ophthalmology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Retinal Vein Occlusion 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Retinal Vein Occlusion Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Retinal Vein Occlusion 33
Apr 23, 2015: ThromboGenics Starts Evaluating JETREA for the Treatment of Retinal Vein Occlusion 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
Actavis plc 36
Clinical Trial Overview of Actavis plc 36
F. Hoffmann-La Roche Ltd. 38
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 38
Regeneron Pharmaceuticals, Inc. 40
Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 40
Bayer AG 41
Clinical Trial Overview of Bayer AG 41
Valeant Pharmaceuticals International, Inc. 42
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 42
S:t Eriks Ogonsjukhus AB 43
Clinical Trial Overview of S:t Eriks Ogonsjukhus AB 43
Pfizer Inc. 44
Clinical Trial Overview of Pfizer Inc. 44
California Retina Consultants 45
Clinical Trial Overview of California Retina Consultants 45
Asociacion para Evitar la Ceguera en Mexico I.A.P. 46
Clinical Trial Overview of Asociacion para Evitar la Ceguera en Mexico I.A.P. 46
Clinical Trial Overview of Top Institutes / Government 47
Shahid Beheshti University of Medical Sciences 47
Clinical Trial Overview of Shahid Beheshti University of Medical Sciences 47
National Eye Institute 48
Clinical Trial Overview of National Eye Institute 48
Shiga University of Medical Science 49
Clinical Trial Overview of Shiga University of Medical Science 49
Barnes Retina Institute 50
Clinical Trial Overview of Barnes Retina Institute 50
Duke University 51
Clinical Trial Overview of Duke University 51
Hallym University Medical Center 52
Clinical Trial Overview of Hallym University Medical Center 52
Manhattan Eye Ear & Throat Hospital 53
Clinical Trial Overview of Manhattan Eye Ear & Throat Hospital 53
Medical University of Vienna 54
Clinical Trial Overview of Medical University of Vienna 54
Mie University 55
Clinical Trial Overview of Mie University 55
Palo Alto Medical Foundation 56
Clinical Trial Overview of Palo Alto Medical Foundation 56
Five Key Clinical Profiles 57
Appendix 125
Abbreviations 125
Definitions 125
Research Methodology 126
Secondary Research 126
About GlobalData 127
Contact Us 127
Disclaimer 127
Source 127